Foundation / Corporation
04/10/19 8:00 PM ET
Grants to USA, Canada, and International nonprofit and for-profit institutions, IHEs, hospitals, government entities, research and development entities, and individuals for investigative research related to autism. Applicants must submit an LOI prior to submitting a full application.
Autism Speaks is seeking novel grant applications to increase the basic understanding of autism – from genetics to behavior – by analyzing important datasets generated by Autism Speaks through its many programs and partnerships. Applications that co-analyze both Autism Speaks and non-Autism Speaks datasets in combination are encouraged. However, these grants are not for collecting new data but are to give researchers support to investigate new hypotheses or relationships using these datasets. These autism-specific datasets include the Autism Genetics Research Exchange (AGRE) and MSSNG genetics resource (pronounced “Missing” to represent information that is missing to understand autism.)
The goal of this Request for Applications (RFA) is to advance understanding of the molecular underpinnings of ASD and how these changes relate to behavioral outcomes and might be assessed as autism subtypes. A successful application will require the use of at least one of these two resources as the primary source of data to be analyzed to support the hypothesis proposed. Other non-Autism Speaks datasets can be co-analyzed to allow larger dataset to be studied in aggregate. A wide variety of proposals are encouraged to use these Autism Speaks datasets to advance understanding of ASD risk by exploring novel hypotheses, new genetic-phenotypic relationships and new science to support clinical assessments or treatments.
Grant proposals using AGRE and/or MSSNG datasets can include, but are not exclusive to developing methods to: identify ASD subtypes, advance understanding of how genetics can improve diagnostic certainty, enable earlier diagnosis and/or deepen understanding of genetic pathways in ways that could lead to identifying targets for improved treatments and health outcomes.
Finally, an important goal this program is to bring early career investigators to autism genetics and have them explore MSSNG resources. Additionally, investigators from other fields are encouraged to apply.
Applicants should contact Autism Speaks regarding sample availability or any questions regarding the available resources that influence their proposal.
GrantWatch ID#: 185144
Up to four
$100,000 inclusive of 10% indirects.
Applicants at U.S. and non-U.S. non-profit and for-profit institutions are eligible for this program. These entities include, but are not limited to, colleges, universities, hospitals, governmental entities and for-profit research & development entities (e.g. biotechnology and pharmaceutical companies).
Projects involving for-profit entities require a letter from an authorized company representative declaring that the applicant’s work can and will be published, and that publication will not be delayed (or without proper justification) because of proprietary issues.
Early Career Investigator: Preference will be given to early career investigators, who are defined as a postdoctoral fellow or an assistant professor with three or fewer years at this rank. Under special circumstances, senior investigators can apply if they will be providing funds to cosupport the salary of an early career investigator. Additionally, investigators from other fields are encouraged to apply to advance novel hypotheses.
There are no geographic restrictions on these applications. International applicants are encouraged.
Please Note: Applicants must be an early career scientist, unless a justification is made for an exception as described in eligibility above.
Funds are intended to be used primarily for salaries and resources to complete the project. Any funding for heavy storage and computing costs must be discussed in the proposal.
Letter of Intent due on or before: March 6, 2019, 8:00 pm (U.S. Eastern Time)
Letter of Intent decisions: Mid-March
Application due on or before: April 10, 2019, 8:00 pm (ET)
Other Important Dates (subject to change):
Peer review panels: Late spring 2019
Notification: Summer 2019
Earliest Grant start date: early fall 2019
All applications must be submitted through the web-based Autism Speaks Science Grants System.
Important Note: LOIs will be subject to in-depth review including PI eligibility. After all LOIs are reviewed, Autism Speaks will send an email indicating approval or disapproval. Please do not contact the grants staff regarding LOI acceptability. Applicants with approved LOIs will be permitted to submit a full application.
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
For inquiries, please contact:
Grants Administration/Online Application/Budget Questions:
Joan New, MBA, Grants Manager
Dean Hartley, PhD, Senior Director, Genomic Discovery and Translational Science;
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
USA Territories: American Samoa (USA) Guam (USA) Puerto Rico (USA) Virgin Islands (USA) Northern Mariana Islands (USA)
USA Compact Free Associations: The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA)
Canada: Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon
International country outside of the USA, Israel and Canada.